Impedance to Defibrillation Countershock: Does an Optimal Impedance Exist?

Pacing and Clinical Electrophysiology

Volumn 18, Issue 11, 1995, Pages 2068-2087

  KENKNIGHT, BRUCE H ^b   MURAT EYUBOGRLU B ^c,d   IDEKER, RAYMOND E ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c DUKE UNIVERSITY   (United States)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

countershock; defibrillation; impedance; implantable defibrillator

Indexed keywords

ARTICLE; CARDIOVERSION; COMPUTER MODEL; DEFIBRILLATION; ELECTRIC CURRENT; ELECTRODE; HUMAN; IMPEDANCE; TISSUE;

ANIMAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC CONDUCTIVITY; ELECTRIC COUNTERSHOCK; ELECTRIC IMPEDANCE; EQUIPMENT DESIGN; EQUIPMENT SAFETY; HEART; HUMAN; MEMBRANE POTENTIALS; MYOCARDIUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; SURFACE PROPERTIES;

EID: 0028806652     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1995.tb03869.x     Document Type: Article

References (141)

1. Epicardial activation following unsuccessful defibrillation shocks in dogs
2. Activation during ventricular defibrillation in open‐chest dogs: Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks
3. Mechanism of cardiac defibrillation in open‐chest dogs with unipolar DC‐coupled simultaneous activation and shock potential recordings
4. Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open chest dogs
5. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs
6. Ventricular fibrillation of long duration abolished by electric shock
7. Electrical treatment of cardiac arrest: A cardiac stimulator‐defibrillator
8. Termination of ventricular fibrillation in man by externally applied electric countershock
9. Optimizing the subcutaneous electrode of a new nonthoracotomy lead system in pigs
10. Current distribution from defibrillation electrodes in a homogeneous torso model
11. Local potential gradients as a unifying measure for thresholds of stimulation, standstill, tachyarrhythmia and fibrillation appearing after strong capacitor discharges
12. Determinations of intracardiac current in defibrillation. Experimental studies in dogs
13. The potential gradient field created by epicardial defibrillation electrodes in dogs
14. Evaluation of a new defibrillation pathway: The tongue‐epigastric route. I. Experimental studies in dogs
15. The impedance of electrodes used for ventricular defibrillation
16. DC pulse defibrillation
17. The design rationale of defibrillators
18. Transthoracic impedance to defibrillator discharge—Effect of electrode size and electrode chest wall interface
19. Transthoracic impedance to direct current discharge—Effect of repeated countershocks
20. Canine transthoracic resistance
21. Experimental studies to design safe external pediatric paddles for a DC defibrillator
22. The interelectrode resistances at defibrillation
23. Thoracic impedance of human subjects
24. Significant determinants of successful reversion of fibrillation by a new DC defibrillator
25. The characterization of human transmyocardial impedance during implantation of the automatic internal cardioverter defibrillator
26. Electrodes for transchest and ICD defibrillation and multifunctional electrodes
27. Inlrathoracic current flow during transthoracic defibrillation in dogs: Transcardiac current fraction
28. The implantable defibrillator: Problems of energy storage and the efficiency of the electrode system
29. Changes in transmyocardial impedance during prolonged ventricular fibrillation: Implications for current flow and delivered energy during DC countershock
30. The discontinuous nature of propagation in normal canine cardiac muscle. Evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents
31. Influence of cardiac fiber orientation on wavefront voltage, conduction velocity, and (tissue resistivity in the dog
32. A volume conductor model of the thorax for the study of defibrillation
33. Finite element analysis of cardiac defibrillation current distributions
34. Skeletal muscle grids for assessing current distributions from defibrillation shocks
35. Effect of microscopic and macroscopic discontinuities on the response of cardiac tissue to defibrillating (stimulating) currents
36. Inclusion of junction elements in a linear cardiac model through secondary sources: Application to defibrillation
37. Periodic conductivity as a mechanism for cardiac stimulation and defibrillation
38. Potential distribution in three‐dimensional periodic myocardium: Part 1. Solution with two‐scale asymptotic analysis
39. Engineering aspects of implantable defibrillators
40. Evaluation of the internal resistance, inductance and capacitance of intact damped sine wave defibrillators
41. Characteristics of the metal‐tissue interface of stimulation electrodes
42. The impedance of stainless‐steel electrodes
43. Engineering and physiological considerations of direct capacitor‐discharge ventricular defibrillation
44. A mathematical model for the polarization impedance of cardiac pacemaker electrodes
45. Temporary pacemaker treatment in open heart surgery: Variation in myocardial threshold, tissue and interface impedances in man
46. Platinum pacemaker electrodes: Origins and effects of the electrode‐tissue interface impedance
47. Factors affecting transthoracic impedance during electrical cardioversion
48. Resistivity of body tissues at low frequencies
49. The specific resistance of biological material: A compendium of data for the biomedical engineer and physiologist
50. Directional differences of impulse spread in trabecular muscle from mammalian heart
51. Optical recordings of the effect of electrical stimulation on action potential repolarization and the induction of reentry in two‐dimensional perfused rabbit epicardium
52. Bipolar stimulation of cardiac tissue using an anisotropic bidomain model
53. A volume conductor model of the thorax for the study of defibrillation fields
54. Optimal electrode designs for electrosurgery, defibrillation, and external cardiac pacing
55. Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation
56. Three‐dimensional potential gradient fields generated by intracardiac catheter and cutaneous patch electrodes
57. Examining the fraction of intrathoracic current that enters ihe heart during transthoracic defibrillation of the human torso
58. Paddle position and size effects in human trans thoracic difibrillation: A three‐dimensional finite element model
59. Improved cardiac cell excitation with symmetrical biphasic defibrillator waveforms
60. Synchronized repolarization after defibrillation shocks: A possible component of the defibrillation process demonstrated by optical recordings in rabbit heart
61. Comparison of alternating current with direct current electroshock across the closed chest
62. Standby automatic defibrillator: An approach to sudden coronary death
63. Experimental ventricular defibrillalion with an automatic and completely implanted system
64. The decrease in transthoracic impedance during successive ventricular defibrillation trials
65. Trannsthoracic defibrillation: Effect of sternotomy on chest impedance
66. Catheter electrode defibrillation in dogs: Threshold dependence on implant time and catheter stability
67. Differences in intersequence system impedance trends for nonthoracotomy defibrillation electrode configurations in pigs
68. Serial patch‐patch impedance values in an epicardial defibrillation system
69. Pericardial effusion increases defibrillalion energy requirement
70. Transthoracic resistance in human defibrillation: Influence of body weight, chest size serial shocks, paddle size and paddle contact pressure
71. Ventricular defibrillation using biphasic waveforms: The importance of phasic duration
72. The prediction of the impedance of the thorax to defibrillating current
73. Determinants of defibrillation: Prospective analysis of 183 patients
74. Utility of low energy test shocks for estimation of cardiac and electrode impedance with implantable defibrillators
75. Inverse relationship of defibrillation impedance delivered
76. Biopotential electrodes
77. Mechanisms responsible for decline in transthoracic impedance to DC shocks
78. Advance prediction of transthoracic impedance in human defibrillation and cardioversion: Importance of impedance in determining the success of low energy shocks
79. Comparison of paddle electrode pastes used for defibrillation
80. New defibrillation electrodes
81. Disposable defibrillator electrodes
82. Electrode pad size, transthoracic impedance and success of external ventricular defibrillation
83. Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator
84. Chronic changes in defibrillation parameters with a transvenous lead system
85. Rise in defibrillation threshold early after implantation of non‐thoracotomy defibrillation lead system: Incidence and predictors
86. Optimum current duration for capacitor‐discharge defibrillation of canine ventricles
87. Implantable cardioverters and dofibrillators
88. Energy, current, and success in defibrillation and cardioversion: Clinical studies using an automated impedance‐based method of energy adjustment
89. Does determination of patch lead impedance by low energy shocks help to identify patients with an insufficient defibrillation threshold
90. Implant Support Devices
91. The role of an engineering oriented medical research group in developing improved methods and devices for achieving ventricular defibrillation: The University of Missouri experience
92. Defibrillation with waveforms other than damped sine wave
93. Optimal waveform morphology for defibrillation
94. Bipolar catheter defibrillation in dogs using trapezoidal waveforms of various tilts
95. The effect of tilt on defibrillation efficacy
96. Relationship between canine transthoracic impedance and defibrillation threshold: Evidence for current‐based defibrillation
97. Current‐ based versus energy‐based ventricular defibrillation: A prospective study
98. Myocardial necrosis from direct current countershock: Effect of paddle size and time interval between discharge
99. Cardiac damage produced by defibrillation
100. Myocardial injury from transthoracic defibrillator countershock
101. Ventricular defibrillation—A comparative trial using 175‐ J and 320‐J shocks
102. Cardiac damage produced by direct current countershock applied to the heart
103. Automated impedance based energy adjustment for defibrillation: Experimental studies
104. Current concepts for selecting the location, size, and shape of defibrillation electrodes
105. Factors concerned in electrical defibrillation of the heart, particularly through the unopened chest
106. Scaling current and energy with body weight: Requirements for the transthoracic ventricular defibrillation of calves as they grow from 50 to 150 kg
107. Effectiveness of direct current defibrillation: Role of paddle electrode size
108. Effectiveness of direct current defibrillation: Role of paddle electrode size: II
109. Ventricular defibrillation in the dog using implanted and partially implanted electrode systems
110. Electrode system for permanent implantable defibrillators: Transvenous catheter and subcutaneous plate electrodes
111. Improved defibrillation thresholds with large contoured electrodes and biphasic waveforms
112. The implanted defibrillator: Relation to dofibrillating lead configuration and clinical variables to defibrillation threshold
113. Comparative efficacy of subcutaneous mesh and plate electrodes for nonthoracotomy canine defibrillation
114. Determination of position sensitivity of a new subcutaneous electrode for implantable defibrillator in pigs
115. Optimum length of subcutaneous array electrode elements
116. Subcutaneous array electrode dramatically reduces defibrillation strength requirements compared to catheter alone in pigs
117. Improved internal defibrillation efficacy with a biphasic waveform
118. A new approach towards defibrillation electrodes: Highly conductive isotropic carbon fibers
119. Increased right ventricular coil length lowers defibrillation thresholds despite reduction in catheter diameter and total electrode surface
120. The SQ array: A new non‐thoracotomy implantable cardinverter defibrillator lead that reduces the defibrillation threshold
121. Subcutaneous array lead for internal defibrillation: a new lead configuration
122. Results and realistic expectations with transvenous lead systems
123. Defibrillation threshold testing using a subcutaneous wire array
124. Evaluation of the current distribution from implantable defibrillation electrodes using image analysis of bubble formation in a homogeneous tank
125. Improved defibrillation efficacy with subcutaneous wires replacing a subcutaneous patch
126. The edge effect of catheter electrodes
127. Defibrillation with low voltage using a left ventricular catheter and four cutaneous patch electrodes in dogs
128. The thoracic windows for electrical ventricular defibrillation currrent
129. Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness
130. Effects of voltage and respiration on impedance in non‐ thoracotomy defibrillation pathways
131. Electroporation of cardiac cell membranes with monophasic or biphasic rectangular pulses
132. Recent advances in cardiopulmonary resuscitation and defibriliation
133. Linearity of transthoracic conductance with respect to electrode force and area during high‐voltage defibrillation shocks
134. Effect of capacitor size and pathway resistance on defibrillation threshold for implantable defibrillators
135. Troubleshooting implantable cardioverter defibrillater system malfunctions: The role of impedance measurements